100
Views
8
CrossRef citations to date
0
Altmetric
Original

Estimation of hydroxyl radical generation by salicylate hydroxylation method in kidney of mice exposed to ferric nitrilotriacetate and potassium bromate

, PhD, , , , , , , & show all
Pages 1246-1252 | Received 08 Aug 2007, Published online: 07 Jul 2009
 

Abstract

Hydroxyl radical (·OH) generation in the kidney of mice treated with ferric nitrilotriacetate (Fe-NTA) or potassium bromate (KBrO3) in vivo was estimated by the salicylate hydroxylation method, using the optimal experimental conditions we recently reported. Induction of DNA lesions and lipid peroxidation in the kidney by these nephrotoxic compounds was also examined. The salicylate hydroxylation method revealed significant increases in the ·OH generation after injection of Fe-NTA or KBrO3 in the kidneys. A significant increase in 8-hydroxy-2′-deoxyguanosine in nuclei of the kidney was detected only in the KBrO3 treated mice, while the comet assay showed that the Fe-NTA and KBrO3 treatments both resulted in significant increases in DNA breakage in the kidney. With respect to lipid peroxidation, the Fe-NTA treatment enhanced lipid peroxidation and ESR signals of the alkylperoxy radical adduct. These DNA breaks and lipid peroxidation mediated by ·OH were diminished by pre-treatment with salicylate in vivo. These results clearly demonstrated the usefulness of the salicylate hydroxylation method as well as the comet assay in estimating the involvement of ·OH generation in cellular injury induced by chemicals in vivo.

Acronyms
hydroxyl radical=

OH

salicylic acid=

SA

acetylsalicylic acid=

ASA

2,3-dihydroxy benzoic acid=

2,3-DHBA

ferric nitrilotriacetate=

Fe-NTA

8-oxo-7,8-dihydro-2′-deoxyguanosine=

8-oxodG

2-deoxyguanosine=

2-dG

Acronyms
hydroxyl radical=

OH

salicylic acid=

SA

acetylsalicylic acid=

ASA

2,3-dihydroxy benzoic acid=

2,3-DHBA

ferric nitrilotriacetate=

Fe-NTA

8-oxo-7,8-dihydro-2′-deoxyguanosine=

8-oxodG

2-deoxyguanosine=

2-dG

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.